NCT02638090 2025-12-22
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
Spanish Lung Cancer Group
Yale University
University of Wisconsin, Madison
National Cancer Institute (NCI)
University of Washington
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC